Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...

Diabetes during pregnancy, whether type 1, type 2, or gestational diabetes, significantly increases the risk of complications for both mother and fetus.

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up ...

A Pittsburgh firm is harnessing artificial intelligence to make it easier for military aircraft to land on ships at sea.

For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the incidence of low glucose while driving, according to a study published in the April ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day Dexcom G7 integrated continuous glucose monitor (CGM) in ...

The No. 1 reason physicians cite for not prescribing a continuous glucose monitor is its complexity, a roadblock that DME ...

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.